Kodiak Sciences Inc.

    Jurisdiction
    United States
    LEI
    254900IXI5NI8C9OQE24
    ISIN
    US50015M1099 (KOD)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    2 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €0.00
    Gross margin
    0.0%
    EBIT
    -€177.55M
    EBIT margin
    0.0%
    Net income
    -€75.38M
    Net margin
    0.0%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    N/A -€229.06M +203.9%
    €55.67M -€250.84M +9.5%
    €161.60M +190.3% -€178.97M -28.7%

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: March 28, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 703K $1.97M +241K Buy

    Add to watchlist

    Notifications